Starling Oncology, Inc. Operating Lease Right-of-Use Assets
Starling Oncology, Inc. (DFPH) had Operating Lease Right-of-Use Assets of $21.19 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $21.19M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $22.52M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $22.37M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $23.27M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $21.19M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $22.52M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $22.37M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $23.27M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $23.89M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $24.21M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $25.78M 10-K · filed 2026-03-12 |
| 2024-09-30 | $27.08M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $26.99M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $27.42M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $29.17M 10-K · filed 2025-03-26 |
| 2023-09-30 | $28.53M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $29.04M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $24.68M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $24.49M 10-K · filed 2024-03-28 |
| 2022-09-30 | $24.81M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $17.25M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $17.23M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |